Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NISHANT VERMA

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1013162817
CMS profile
1319366
Location
CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$99,373.31

140 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NISHANT VERMA

NPI 1013162817 · CMS profile ID 1319366

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1013162817?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NISHANT VERMA, NPI 1013162817, CMS profile ID 1319366. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1013162817?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). NISHANT VERMA, NPI 1013162817, CMS profile ID 1319366. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1013162817?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
NISHANT VERMA, NPI 1013162817, CMS profile ID 1319366, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1013162817?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

140 matching records · $99,373.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 140 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 140.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Boston Scientific Corporation $228.9006/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123930 CMS
Boston Scientific Corporation $29.3806/21/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123932 CMS
Boston Scientific Corporation $228.9006/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123926 CMS
Boston Scientific Corporation $633.0706/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123928 CMS
Abbott Laboratories $21.6906/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240860013 CMS
Boston Scientific Corporation $10,000.0006/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181123872 CMS
Boston Scientific Corporation $625.0006/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181123874 CMS
Boston Scientific Corporation $44.9006/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123876 CMS
Boston Scientific Corporation $122.0006/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123878 CMS
Abbott Laboratories $11.4506/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240752495 CMS
BIOTRONIK INC. $104.1805/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244379000 CMS
Abbott Laboratories $600.0005/29/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240580955 CMS
Abbott Laboratories $600.0005/29/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240580959 CMS
Abbott Laboratories $3,000.0005/29/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240580963 CMS
Abbott Laboratories $1,200.0005/29/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240580967 CMS
Abbott Laboratories $10.1705/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240728653 CMS
Abbott Laboratories $6.2105/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240728655 CMS
Abbott Laboratories $14.9705/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240728657 CMS
Abbott Laboratories $86.0005/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241081379 CMS
Abbott Laboratories $50.0005/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241081381 CMS
Medtronic, Inc. $28.4105/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219873896 CMS
Boston Scientific Corporation $44.8305/19/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123902 CMS
Boston Scientific Corporation $137.9205/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123896 CMS
Boston Scientific Corporation $139.7505/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123898 CMS
Boston Scientific Corporation $139.2805/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123900 CMS
Boston Scientific Corporation $205.8905/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123904 CMS
Boston Scientific Corporation $142.6605/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123906 CMS
Boston Scientific Corporation $521.9605/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123892 CMS
Boston Scientific Corporation $205.8905/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123894 CMS
Abbott Laboratories $181.5505/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240728423 CMS
Biosense Webster, Inc. $108.9805/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174051866 CMS
Boston Scientific Corporation $30.7205/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123880 CMS
Impulse Dynamics (USA) Inc. $9.5405/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223109918 CMS
Biosense Webster, Inc. $5.7505/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174051272 CMS
Impulse Dynamics (USA) Inc. $6.7305/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223109916 CMS
Biosense Webster, Inc. $148.3404/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174050081 CMS
Boston Scientific Corporation $30.3304/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123856 CMS
Boston Scientific Corporation $625.0004/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181123858 CMS
Boston Scientific Corporation $1,500.0004/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181123860 CMS
Boston Scientific Corporation $10,000.0004/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181123862 CMS
Boston Scientific Corporation $122.0004/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1181123864 CMS
Boston Scientific Corporation $8.5004/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181123870 CMS
Abbott Laboratories $57.5304/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750935 CMS
Abbott Laboratories $29.3904/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750937 CMS
Abbott Laboratories $59.0604/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750939 CMS
Abbott Laboratories $41.6304/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750941 CMS
Abbott Laboratories $65.2804/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241084589 CMS
Abbott Laboratories $60.2004/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750929 CMS
Abbott Laboratories $34.9504/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750931 CMS
Abbott Laboratories $173.7204/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240750933 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,776.58 45
PY2020 $140.82 2
PY2021 $9,422.33 32
PY2022 $10,162.96 18
PY2023 $22,432.83 65
PY2024 $80,567.74 138
PY2025 $99,373.31 140

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $25,320.00 13
PY2024 Principal investigator $23,753.00 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $1,334.00 12/12/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213850
Principal investigator 1 Janssen Research & Development, LLC $769.00 11/07/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213807
Principal investigator 1 Janssen Research & Development, LLC $160.00 11/03/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213973
Principal investigator 1 Janssen Research & Development, LLC $942.00 09/19/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213760
Principal investigator 1 Janssen Research & Development, LLC $3,597.00 09/05/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175214003
Principal investigator 1 Janssen Research & Development, LLC $1,584.00 07/07/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213838
Principal investigator 1 Janssen Research & Development, LLC $942.00 06/23/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213997
Principal investigator 1 Janssen Research & Development, LLC $769.00 06/20/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213941
Principal investigator 1 Janssen Research & Development, LLC $856.00 04/23/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213680
Principal investigator 1 Janssen Research & Development, LLC $942.00 03/21/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213737
Principal investigator 1 Janssen Research & Development, LLC $9,379.00 03/14/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213965
Principal investigator 1 Janssen Research & Development, LLC $942.00 02/19/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213688
Principal investigator 1 Janssen Research & Development, LLC $3,104.00 01/22/2025 Non-covered Recipient Entity
Nwn Univ
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175213673